FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PALAZESTRANT
异名/同义词(1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-1-(4-((1-PROPYLAZETIDIN-3- YL)OXY)PHENYL)-2,3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOLE
1H-PYRIDO(3,4-B)INDOLE, 2-(2-FLUORO-2-METHYLPROPYL)-2,3,4,9-TETRAHYDRO-3-METHYL-1-(4-((1-PROPYL-3-AZETIDINYL)OXY)PHENYL)-, (1R,3R)-
OP-1250
PALAZESTRANT [USAN]
PALAZESTRANT
PALAZESTRANT [WHO-DD]
PALAZESTRANT [INN]
CAS登记号2092925-89-6
物质唯一标识(Unique Ingredient Identifier)VU35KM56Q4
分子式C28H36FN3O
国际化合物标识(International Chemical Identifier,InChI)LBSFUBLFDCAEKV-XHCCPWGMSA-N
SMILESC(C(C)(C)F)N1[C@@H](c2c(C[C@H]1C)c3c([nH]2)cccc3)c4ccc(cc4)OC5CN(C5)CCC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System